Showing 221 - 240 results of 65,046 for search '(( 5 ((ppm decrease) OR (((mean decrease) OR (a decrease)))) ) OR ( 5 ht decrease ))', query time: 0.83s Refine Results
  1. 221

    A summary of the included study characteristics. by Zahra Tajik (20752452)

    Published 2025
    “…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
  2. 222
  3. 223
  4. 224
  5. 225

    Image 5_Using sodium glycodeoxycholate to develop a temporary infant-like gut barrier model, in vitro.pdf by Francesca Bietto (21511316)

    Published 2025
    “…</p>Methods<p>This study aimed to develop an in vitro model of the infant gut barrier treating Caco-2/HT29-MTX with 0.5, 0.8, and 1 mM sodium glycodeoxycholate (GDC).…”
  6. 226
  7. 227
  8. 228

    CM-DWM-EC chart using 30% decrease in the mean for the E(KeV). by Shumaila Nisar (20114256)

    Published 2024
    “…<p>CM-DWM-EC chart using 30% decrease in the mean for the E(KeV).</p>…”
  9. 229
  10. 230
  11. 231
  12. 232
  13. 233

    Developmental change in 5-HT<sub>1A</sub> binding in known cause of death controls (predischarge and postdischarge combined). by Hannah C. Kinney (10280975)

    Published 2025
    “…Binding in these nuclei are visually (top row) and quantitatively (bottom row) decreasing with PC age, the latter shown with plots of 5-HT<sub>1A</sub> binding vs PC age. …”
  14. 234
  15. 235
  16. 236
  17. 237
  18. 238
  19. 239
  20. 240

    Synthesis, Radiolabeling, and in Vitro and in Vivo Evaluation of [<sup>18</sup>F]ENL30: A Potential PET Radiotracer for the 5‑HT<sub>7</sub> Receptor by Elina Tampio L’Estrade (6619937)

    Published 2019
    “…The 5-HT<sub>7</sub> receptor (5-HT<sub>7</sub>R) is involved in a broad range of physiological conditions and disorders. …”